/Companies

Nura Bio

4 known investors

Find your way into Nura Bio

Sign up to see every warm intro you have to Nura Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nura Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nura Bio develops neuroprotective medicines targeting neurological diseases by translating scientific advances in axonal degeneration and neuroimmune regulation into novel therapeutics.

Investors · 4

Also in the syndicate · 1

Euclidean Capital

Funding

SEC filings, press & company announcements

$73.8M disclosed across 1 of 3 rounds · 2024–2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Nura Bio do?
Nura Bio develops neuroprotective medicines targeting neurological diseases by translating scientific advances in axonal degeneration and neuroimmune regulation into novel therapeutics.
Who are Nura Bio's investors?
Nura Bio's investors include The Column Group, Samsara BioCapital, Sanofi Ventures.
How much funding has Nura Bio raised?
Nura Bio has disclosed $73.8M raised across 1 of its 3 known rounds.